These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 9885940
1. Hypoxic cell cytotoxin tirapazamine induces acute changes in tumor energy metabolism and pH: a 31P magnetic resonance spectroscopy study. Aboagye EO, Dillehay LE, Bhujwalla ZM, Lee DJ. Radiat Oncol Investig; 1998; 6(6):249-54. PubMed ID: 9885940 [Abstract] [Full Text] [Related]
2. Effects of pentobarbital anesthesia on the energy metabolism of murine tumors studied by in vivo 31P nuclear magnetic resonance spectroscopy. Okunieff P, Rummeny E, Vaupel P, Skates S, Willett C, Neuringer LJ, Suit HD. Radiat Res; 1988 Aug; 115(2):361-72. PubMed ID: 3406373 [Abstract] [Full Text] [Related]
4. 31P nuclear magnetic resonance spectroscopy studies of tumor energy metabolism and its relationship to intracapillary oxyhemoglobin saturation status and tumor hypoxia. Rofstad EK, DeMuth P, Fenton BM, Sutherland RM. Cancer Res; 1988 Oct 01; 48(19):5440-6. PubMed ID: 3416301 [Abstract] [Full Text] [Related]
6. Correlation of radiobiological assays of hypoxic fraction with phosphorus-31 magnetic resonance spectroscopy across multiple tumor lines. Li SJ, Jin GY, Fish BL, Moulder JE. Radiat Res; 1995 Jul 01; 143(1):45-53. PubMed ID: 7597143 [Abstract] [Full Text] [Related]
8. Reduction of intratumoral pH by the mitochondrial inhibitor m-iodobenzylguanidine and moderate hyperglycemia. Kuin A, Smets L, Volk T, Paans A, Adams G, Atema A, Jähde E, Maas A, Rajewsky MF, Visser G. Cancer Res; 1994 Jul 15; 54(14):3785-92. PubMed ID: 8033098 [Abstract] [Full Text] [Related]
9. Dose-dependent thermal response of tumor pH and energy metabolism evaluated by in vivo 31P NMR spectroscopy and microelectrodes. Jiang Q, Chopp M, Kovich K, Johnson C, Hetzel FW. Radiat Res; 1991 Aug 15; 127(2):177-83. PubMed ID: 1947002 [Abstract] [Full Text] [Related]
10. Effects of temperature on intracellular sodium, pH and cellular energy status in RIF-1 tumor cells. Babsky A, Hekmatyar SK, Wehrli S, Nelson D, Bansal N. NMR Biomed; 2004 Feb 15; 17(1):33-42. PubMed ID: 15011249 [Abstract] [Full Text] [Related]
11. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy. Muruganandham M, Alfieri AA, Matei C, Chen Y, Sukenick G, Schemainda I, Hasmann M, Saltz LB, Koutcher JA. Clin Cancer Res; 2005 May 01; 11(9):3503-13. PubMed ID: 15867253 [Abstract] [Full Text] [Related]
12. Pharmacokinetics and bioreductive metabolism of the novel benzotriazine di-N-oxide hypoxic cell cytotoxin tirapazamine (WIN 59075; SR 4233; NSC 130181) in mice. Walton MI, Workman P. J Pharmacol Exp Ther; 1993 May 01; 265(2):938-47. PubMed ID: 8496834 [Abstract] [Full Text] [Related]
13. Tumor dose response to the vascular disrupting agent, 5,6-dimethylxanthenone-4-acetic acid, using in vivo magnetic resonance spectroscopy. McPhail LD, Chung YL, Madhu B, Clark S, Griffiths JR, Kelland LR, Robinson SP. Clin Cancer Res; 2005 May 15; 11(10):3705-13. PubMed ID: 15897567 [Abstract] [Full Text] [Related]
14. The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow. Koutcher JA, Motwani M, Zakian KL, Li XK, Matei C, Dyke JP, Ballon D, Yoo HH, Schwartz GK. Clin Cancer Res; 2000 Apr 15; 6(4):1498-507. PubMed ID: 10778982 [Abstract] [Full Text] [Related]
15. Detecting vascular-targeting effects of the hypoxic cytotoxin tirapazamine in tumor xenografts using magnetic resonance imaging. Bains LJ, Baker JH, Kyle AH, Minchinton AI, Reinsberg SA. Int J Radiat Oncol Biol Phys; 2009 Jul 01; 74(3):957-65. PubMed ID: 19480975 [Abstract] [Full Text] [Related]
16. Cellular energetics measured by phosphorous nuclear magnetic resonance spectroscopy are not correlated with chronic nutrient deficiency in multicellular tumor spheroids. Freyer JP, Schor PL, Jarrett KA, Neeman M, Sillerud LO. Cancer Res; 1991 Aug 01; 51(15):3831-7. PubMed ID: 1855200 [Abstract] [Full Text] [Related]
17. Loss of high-energy phosphate following hyperthermia demonstrated by in vivo 31P-nuclear magnetic resonance spectroscopy. Lilly MB, Ng TC, Evanochko WT, Katholi CR, Kumar NG, Elgavish GA, Durant JR, Hiramoto R, Ghanta V, Glickson JD. Cancer Res; 1984 Feb 01; 44(2):633-8. PubMed ID: 6581861 [Abstract] [Full Text] [Related]
18. Spatial heterogeneity of the metabolic response of RIF-1 tumors to a vasoactive agent evaluated in vivo by one-dimensional 31P chemical-shift imaging. Bhujwalla ZM, Blackband SJ, Wehrle JP, Glickson JD. Magn Reson Med; 1992 Aug 01; 26(2):308-12. PubMed ID: 1513252 [Abstract] [Full Text] [Related]
19. Radiation dose-dependent changes in tumor metabolism measured by 31P nuclear magnetic resonance spectroscopy. Mahmood U, Alfieri AA, Thaler H, Cowburn D, Koutcher JA. Cancer Res; 1994 Sep 15; 54(18):4885-91. PubMed ID: 8069854 [Abstract] [Full Text] [Related]
20. Tirapazamine-induced cytotoxicity and DNA damage in transplanted tumors: relationship to tumor hypoxia. Siim BG, Menke DR, Dorie MJ, Brown JM. Cancer Res; 1997 Jul 15; 57(14):2922-8. PubMed ID: 9230202 [Abstract] [Full Text] [Related] Page: [Next] [New Search]